A detailed history of Campbell Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Campbell Wealth Management holds 822 shares of AMGN stock, worth $264,856. This represents 0.08% of its overall portfolio holdings.

Number of Shares
822
Previous 818 0.49%
Holding current value
$264,856
Previous $233,000 10.3%
% of portfolio
0.08%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$262.75 - $319.31 $1,051 - $1,277
4 Added 0.49%
822 $257,000
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $219,935 - $265,490
818 New
818 $233,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $178,199 - $221,239
815 New
815 $219,000
Q3 2020

Nov 02, 2020

SELL
$234.65 - $260.95 $50,919 - $56,626
-217 Closed
0 $0
Q2 2020

Jul 23, 2020

BUY
$197.81 - $242.74 $42,924 - $52,674
217 New
217 $51,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Campbell Wealth Management Portfolio

Follow Campbell Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Campbell Wealth Management with notifications on news.